Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JOHN C REED

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1194706531
CMS profile
326401
Location
ROSWELL, GA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$3,085.96

192 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $3,085.96 192

By paying entity

PY2022 · entire year · sorted by reported total

Page 2 of 4; records 51–100 of 192 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JOHN C REED

NPI 1194706531 · CMS profile ID 326401

Allopathic & Osteopathic Physicians / Internal Medicine / Endocrinology, Diabetes & Metabolism

ROSWELL, GA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 4; records 51–100 of 192 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1194706531?year=2022&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JOHN C REED, NPI 1194706531, CMS profile ID 326401. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 192 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1194706531?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). JOHN C REED, NPI 1194706531, CMS profile ID 326401. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 192 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1194706531?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
JOHN C REED, NPI 1194706531, CMS profile ID 326401, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 4; records 51–100 of 192 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1194706531?year=2022&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

192 matching records · $3,085.96 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 192 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 192.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Novo Nordisk Inc $12.1409/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898581269 CMS
Novo Nordisk Inc $17.2709/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898950373 CMS
Insulet Corporation $25.2409/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 933162931 CMS
Novo Nordisk Inc $2.8609/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899648363 CMS
SANOFI-AVENTIS U.S. LLC $19.3109/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938757731 CMS
Novartis Pharmaceuticals Corporation $13.8009/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894273883 CMS
Novo Nordisk Inc $17.8009/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899496203 CMS
Novartis Pharmaceuticals Corporation $17.3009/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894273887 CMS
SANOFI-AVENTIS U.S. LLC $21.3109/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938757733 CMS
Ultragenyx Pharmaceutical Inc. $21.6708/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 963745211 CMS
Amgen Inc. $15.6208/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939281943 CMS
Novartis Pharmaceuticals Corporation $16.8108/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894273879 CMS
Alexion Pharmaceuticals, Inc. $14.5208/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914715403 CMS
Corcept Therapeutics $16.7808/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 948804935 CMS
Acerus Pharmaceuticals Corporation $20.6908/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 906685087 CMS
Lilly USA, LLC $15.0808/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918142785 CMS
Abbott Laboratories $11.1108/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 910313187 CMS
Novo Nordisk Inc $19.3608/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898998847 CMS
IBSA Pharma Inc. $17.5408/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890042735 CMS
Lilly USA, LLC $18.3908/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918099599 CMS
Novo Nordisk Inc $15.9708/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898674741 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $19.9108/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887753247 CMS
Medtronic, Inc. $21.8208/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930540075 CMS
Novo Nordisk Inc $7.2808/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898853264 CMS
Abbott Laboratories $11.1108/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908573961 CMS
Tandem Diabetes Care, Inc. $18.1608/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 963184199 CMS
Mannkind Corporation $15.2908/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942764921 CMS
Novo Nordisk Inc $11.8407/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899496197 CMS
Amgen Inc. $14.7907/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939281941 CMS
Novo Nordisk Inc $18.4107/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898581275 CMS
Corcept Therapeutics $16.6207/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 948804891 CMS
Abbott Laboratories $11.6907/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920433771 CMS
Amgen Inc. $9.2807/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939281947 CMS
Esperion Therapeutics, Inc. $19.7707/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 947278935 CMS
SANOFI-AVENTIS U.S. LLC $28.7307/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938757707 CMS
Novartis Pharmaceuticals Corporation $20.7207/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894273875 CMS
Novo Nordisk Inc $12.8606/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898853157 CMS
Xeris Pharmaceuticals, Inc. $41.7806/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 946480185 CMS
Medtronic, Inc. $15.8206/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930540071 CMS
Lilly USA, LLC $13.8206/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918088327 CMS
Lilly USA, LLC $0.8806/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918088329 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.3506/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887753241 CMS
Lilly USA, LLC $19.9306/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918142787 CMS
Novo Nordisk Inc $12.1306/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898853149 CMS
Insulet Corporation $27.5506/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 933147101 CMS
Novo Nordisk Inc $19.5106/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898950365 CMS
Abbott Laboratories $18.4706/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908573965 CMS
Xeris Pharmaceuticals, Inc. $21.7906/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 946480183 CMS
Ultragenyx Pharmaceutical Inc. $19.8306/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 963740649 CMS
Lilly USA, LLC $18.4006/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918144127 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $5,468.54 198
PY2020 $551.55 31
PY2021 $12,415.92 232
PY2022 $3,085.96 192
PY2023 $3,297.06 180
PY2024 $2,239.57 113

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $591,132.48 176
PY2024 Principal investigator $429,365.68 106
PY2023 Recipient $932.96 2
PY2023 Principal investigator $465,732.31 320
PY2022 Recipient $495.00 2
PY2022 Principal investigator $766,067.75 861
PY2021 Principal investigator $1,340,208.06 1,551
PY2020 Recipient $20.13 1
PY2020 Principal investigator $794,928.73 470
PY2019 Recipient $14,772.83 9
PY2019 Principal investigator $1,311,543.60 373

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

176 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $5,692.00 12/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
A Phase 2/3 multicenter, double blinded, randomized, dose-conversion, active control study examining the efficacy and safety of Armour Thyroid compared to synthetic T4 for the treatment of adults with primary hypothyroidism No dispute reported 06/30/2026 1202534669
Principal investigator 1 Sequel Med Tech, LLC $488.00 12/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243758632
Principal investigator 1 Sequel Med Tech, LLC $146.40 12/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243758638
Principal investigator 1 Sequel Med Tech, LLC $488.00 12/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243758644
Principal investigator 1 Sequel Med Tech, LLC $146.40 12/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243758649
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 12/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243758654
Principal investigator 1 Sequel Med Tech, LLC $960.00 12/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243758659
Principal investigator 1 Sequel Med Tech, LLC $488.00 12/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243758665
Principal investigator 1 Sequel Med Tech, LLC $146.40 12/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243758675
Principal investigator 1 Sequel Med Tech, LLC $488.00 12/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243758681
Principal investigator 1 Sequel Med Tech, LLC $146.40 12/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243758686
Principal investigator 1 Sequel Med Tech, LLC $8,000.00 12/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243758694
Principal investigator 1 Sequel Med Tech, LLC $2,400.00 12/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243758707
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 12/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243758712
Principal investigator 1 Sequel Med Tech, LLC $960.00 12/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243758718
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 12/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243758722
Principal investigator 1 Sequel Med Tech, LLC $960.00 12/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243758728
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 12/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243758733
Principal investigator 1 Sequel Med Tech, LLC $960.00 12/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243758746
Principal investigator 1 Sequel Med Tech, LLC $2,223.00 12/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243758753
Principal investigator 1 Sequel Med Tech, LLC $666.90 12/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243758758
Principal investigator 1 ABBVIE INC. $2,583.10 12/05/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202529484
Principal investigator 1 Sequel Med Tech, LLC $488.00 11/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243754090
Principal investigator 1 Sequel Med Tech, LLC $146.40 11/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243754097
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 11/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243754103
Principal investigator 1 Sequel Med Tech, LLC $960.00 11/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243754109
Principal investigator 1 Sequel Med Tech, LLC $2,223.00 11/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243754115
Principal investigator 1 Sequel Med Tech, LLC $666.90 11/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243754128
Principal investigator 1 Sequel Med Tech, LLC $488.00 11/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243754136
Principal investigator 1 Sequel Med Tech, LLC $146.40 11/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243754142
Principal investigator 1 Sequel Med Tech, LLC $488.00 11/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243754148
Principal investigator 1 Sequel Med Tech, LLC $146.40 11/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243754154
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 11/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243754158
Principal investigator 1 Sequel Med Tech, LLC $960.00 11/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243754164
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 11/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243754170
Principal investigator 1 Sequel Med Tech, LLC $960.00 11/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243754176
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 11/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243754183
Principal investigator 1 Sequel Med Tech, LLC $960.00 11/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243754189
Principal investigator 1 Sequel Med Tech, LLC $488.00 11/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243754193
Principal investigator 1 Sequel Med Tech, LLC $146.40 11/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243754200
Principal investigator 1 ABBVIE INC. $44,899.40 11/05/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202521775
Principal investigator 1 Sequel Med Tech, LLC $488.00 10/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243751074
Principal investigator 1 Sequel Med Tech, LLC $146.40 10/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243751080
Principal investigator 1 Sequel Med Tech, LLC $488.00 10/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243751084
Principal investigator 1 Sequel Med Tech, LLC $146.40 10/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243751090
Principal investigator 1 Sequel Med Tech, LLC $2,223.00 10/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243751094
Principal investigator 1 Sequel Med Tech, LLC $666.90 10/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243751100
Principal investigator 1 Sequel Med Tech, LLC $2,223.00 10/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243751105
Principal investigator 1 Sequel Med Tech, LLC $666.90 10/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243751109
Principal investigator 1 Sequel Med Tech, LLC $488.00 10/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243751114
Principal investigator 1 Sequel Med Tech, LLC $146.40 10/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243751120
Principal investigator 1 Sequel Med Tech, LLC $488.00 10/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243751124
Principal investigator 1 Sequel Med Tech, LLC $146.40 10/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243751130
Principal investigator 1 Sequel Med Tech, LLC $2,223.00 10/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243751136
Principal investigator 1 Sequel Med Tech, LLC $666.90 10/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243751138
Principal investigator 1 Sequel Med Tech, LLC $2,223.00 10/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243751143
Principal investigator 1 Sequel Med Tech, LLC $666.90 10/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243751149
Principal investigator 1 Sequel Med Tech, LLC $488.00 10/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243751155
Principal investigator 1 Sequel Med Tech, LLC $146.40 10/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243751163
Principal investigator 1 Sequel Med Tech, LLC $488.00 10/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243751173
Principal investigator 1 Sequel Med Tech, LLC $146.40 10/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243751179
Principal investigator 1 Sequel Med Tech, LLC $488.00 10/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243751185
Principal investigator 1 Sequel Med Tech, LLC $146.40 10/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243751191
Principal investigator 1 Sequel Med Tech, LLC $488.00 10/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243751197
Principal investigator 1 Sequel Med Tech, LLC $146.40 10/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243751202
Principal investigator 1 Novo Nordisk AS $110.80 10/29/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS, INC
NN9535-4352 No dispute reported 06/30/2026 1213833576
Principal investigator 1 ABBVIE INC. $37,508.90 10/09/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202514555
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 09/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243748169
Principal investigator 1 Sequel Med Tech, LLC $960.00 09/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243748176
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 09/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243748181
Principal investigator 1 Sequel Med Tech, LLC $960.00 09/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243748186
Principal investigator 1 Sequel Med Tech, LLC $488.00 09/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243748192
Principal investigator 1 Sequel Med Tech, LLC $146.40 09/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243748198
Principal investigator 1 Sequel Med Tech, LLC $488.00 09/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243748204
Principal investigator 1 Sequel Med Tech, LLC $146.40 09/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243748209
Principal investigator 1 Sequel Med Tech, LLC $488.00 09/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243748214
Principal investigator 1 Sequel Med Tech, LLC $146.40 09/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243748220
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 09/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243748225
Principal investigator 1 Sequel Med Tech, LLC $960.00 09/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243748230
Principal investigator 1 Sequel Med Tech, LLC $488.00 09/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243748236
Principal investigator 1 Sequel Med Tech, LLC $146.40 09/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243748241
Principal investigator 1 Sequel Med Tech, LLC $488.00 09/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243748246
Principal investigator 1 Sequel Med Tech, LLC $146.40 09/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243748253
Principal investigator 1 Sequel Med Tech, LLC $2,223.00 09/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243748258
Principal investigator 1 Sequel Med Tech, LLC $666.90 09/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243748264
Principal investigator 1 Sequel Med Tech, LLC $488.00 09/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243748272
Principal investigator 1 Sequel Med Tech, LLC $146.40 09/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243748277
Principal investigator 1 Sequel Med Tech, LLC $488.00 09/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243748283
Principal investigator 1 Sequel Med Tech, LLC $146.40 09/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243748288
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 09/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243748296
Principal investigator 1 Sequel Med Tech, LLC $960.00 09/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243748301
Principal investigator 1 Sequel Med Tech, LLC $2,223.00 09/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243748308
Principal investigator 1 Sequel Med Tech, LLC $666.90 09/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243748314
Principal investigator 1 ABBVIE INC. $32,173.70 09/04/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202508660
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 08/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243746385
Principal investigator 1 Sequel Med Tech, LLC $960.00 08/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243746392
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 08/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243746395
Principal investigator 1 Sequel Med Tech, LLC $960.00 08/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243746400
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 08/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243746407
Principal investigator 1 Sequel Med Tech, LLC $960.00 08/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243746412
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 08/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243746418
Principal investigator 1 Sequel Med Tech, LLC $960.00 08/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243746424
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 08/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243746429
Principal investigator 1 Sequel Med Tech, LLC $960.00 08/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243746435
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 08/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243746439
Principal investigator 1 Sequel Med Tech, LLC $960.00 08/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243746445
Principal investigator 1 Sequel Med Tech, LLC $488.00 08/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243746450
Principal investigator 1 Sequel Med Tech, LLC $146.40 08/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243746458
Principal investigator 1 Sequel Med Tech, LLC $1,175.00 08/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243746463
Principal investigator 1 Sequel Med Tech, LLC $352.50 08/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243746469
Principal investigator 1 Sequel Med Tech, LLC $488.00 08/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243746475
Principal investigator 1 Sequel Med Tech, LLC $146.40 08/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243746481
Principal investigator 1 Sequel Med Tech, LLC $488.00 08/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243746487
Principal investigator 1 Sequel Med Tech, LLC $146.40 08/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243746494
Principal investigator 1 ABBVIE INC. $49,254.40 08/06/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202502590
Principal investigator 1 Sequel Med Tech, LLC $2,223.00 07/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243745303
Principal investigator 1 Sequel Med Tech, LLC $666.90 07/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243745307
Principal investigator 1 Sequel Med Tech, LLC $2,223.00 07/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243745313
Principal investigator 1 Sequel Med Tech, LLC $666.90 07/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243745318
Principal investigator 1 Sequel Med Tech, LLC $488.00 07/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243745321
Principal investigator 1 Sequel Med Tech, LLC $146.40 07/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243745326
Principal investigator 1 Sequel Med Tech, LLC $488.00 07/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243745332
Principal investigator 1 Sequel Med Tech, LLC $146.40 07/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243745338
Principal investigator 1 Sequel Med Tech, LLC $2,223.00 07/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243745344
Principal investigator 1 Sequel Med Tech, LLC $666.90 07/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243745349
Principal investigator 1 Novo Nordisk AS $361.17 07/18/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS, INC
NN9535-4352 No dispute reported 06/30/2026 1213815325
Principal investigator 1 ABBVIE INC. $47,234.20 07/02/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202494253
Principal investigator 1 Sequel Med Tech, LLC $488.00 06/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744750
Principal investigator 1 Sequel Med Tech, LLC $146.40 06/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744758
Principal investigator 1 Sequel Med Tech, LLC $488.00 06/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744765
Principal investigator 1 Sequel Med Tech, LLC $146.40 06/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744772
Principal investigator 1 Sequel Med Tech, LLC $488.00 06/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744778
Principal investigator 1 Sequel Med Tech, LLC $146.40 06/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744786
Principal investigator 1 Sequel Med Tech, LLC $488.00 06/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744790
Principal investigator 1 Sequel Med Tech, LLC $146.40 06/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744798
Principal investigator 1 Sequel Med Tech, LLC $488.00 06/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744803
Principal investigator 1 Sequel Med Tech, LLC $146.40 06/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744810
Principal investigator 1 Sequel Med Tech, LLC $488.00 06/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744816
Principal investigator 1 Sequel Med Tech, LLC $146.40 06/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744821
Principal investigator 1 Sequel Med Tech, LLC $488.00 06/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744825
Principal investigator 1 Sequel Med Tech, LLC $146.40 06/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744831
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 06/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744838
Principal investigator 1 Sequel Med Tech, LLC $960.00 06/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744843
Principal investigator 1 Sequel Med Tech, LLC $488.00 06/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744849
Principal investigator 1 Sequel Med Tech, LLC $146.40 06/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744855
Principal investigator 1 Sequel Med Tech, LLC $488.00 06/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744862
Principal investigator 1 Sequel Med Tech, LLC $146.40 06/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744867
Principal investigator 1 Sequel Med Tech, LLC $488.00 06/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744872
Principal investigator 1 Sequel Med Tech, LLC $146.40 06/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744879
Principal investigator 1 ABBVIE INC. $60,219.90 06/03/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202489365
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 05/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243743984
Principal investigator 1 Sequel Med Tech, LLC $960.00 05/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243743988
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 05/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243743994
Principal investigator 1 Sequel Med Tech, LLC $960.00 05/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243743998
Principal investigator 1 Sequel Med Tech, LLC $488.00 05/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744004
Principal investigator 1 Sequel Med Tech, LLC $146.40 05/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744009
Principal investigator 1 Sequel Med Tech, LLC $488.00 05/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744015
Principal investigator 1 Sequel Med Tech, LLC $146.40 05/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744021
Principal investigator 1 Sequel Med Tech, LLC $488.00 05/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744027
Principal investigator 1 Sequel Med Tech, LLC $146.40 05/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243744031
Principal investigator 1 ABBVIE INC. $23,182.90 05/07/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202483511
Principal investigator 1 Sequel Med Tech, LLC $8,000.00 04/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243743468
Principal investigator 1 Sequel Med Tech, LLC $2,400.00 04/30/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243743475
Principal investigator 1 Medtronic, Inc. $4,375.00 04/22/2025 Non-covered Recipient Entity
Southeastern Endocrine & Diabetes Pc
CIP341 IMPACT2 No dispute reported 06/30/2026 1192322785
Principal investigator 1 Novo Nordisk AS $531.81 04/21/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS, INC
NN9535-4352 No dispute reported 06/30/2026 1213710806
Principal investigator 1 Novo Nordisk AS $741.06 04/21/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS, INC
NN9535-4352 No dispute reported 06/30/2026 1213793517
Principal investigator 1 ABBVIE INC. $34,589.10 04/03/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202473712
Principal investigator 1 Sequel Med Tech, LLC $4,000.00 03/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243743381
Principal investigator 1 Sequel Med Tech, LLC $1,200.00 03/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243743388
Principal investigator 1 Novo Nordisk AS $24,999.27 03/28/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS, INC
EX9924-4473 No dispute reported 06/30/2026 1213703304
Principal investigator 1 ABBVIE INC. $29,840.20 03/07/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS
M21-341 - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202461145
Principal investigator 1 ABBVIE INC. $13,392.60 02/06/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS
M21-341 - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202447492
Principal investigator 1 Eli Lilly and Company $395.00 01/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
A PHASE 3 RANDOMIZED DOUBLE BLIND STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF ONCE DAILY ORAL LY3502970 COMPARED WITH PLACEBO IN ADULT PARTICIPANTS WITH OBESITY OR OVERWEIGHT AND TYPE 2 DIABETES (ATTAIN-2) No dispute reported 06/30/2026 1187880295
Principal investigator 1 Novo Nordisk AS $500.00 01/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS, INC
EX9924-4473 No dispute reported 06/30/2026 1213747853
Principal investigator 1 Novo Nordisk AS $361.17 01/31/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS, INC
NN9535-4352 No dispute reported 06/30/2026 1213809573
Principal investigator 1 Eli Lilly and Company $5,500.00 01/21/2025 Non-covered Recipient Entity
ENDOCRINE RESEARCH SOLUTIONS INC
A PHASE 3 RANDOMIZED DOUBLE BLIND STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF ONCE DAILY ORAL LY3502970 COMPARED WITH PLACEBO IN ADULT PARTICIPANTS WITH OBESITY OR OVERWEIGHT AND TYPE 2 DIABETES (ATTAIN-2) No dispute reported 06/30/2026 1187883074